Clinical Trials · NCT07891156
Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.
- Phase
- Phase 2/Phase 3
- Recruitment status
- Recruiting
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Enrollment
- 40
- Start date
- Oct 2026
- Locations
- 1 site, Canada
- Primary endpoint
- Change in lean mass